Circovac is now accepted for piglets by the Committee for Medicinal Products for Veterinary Use
Lyon, 18.10.10 – Extract from European Medicines Agency website www.ema.europa.eu/ema/index - Pending EC decisions
“On 13 October 2010, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted a positive opinion, recommending to grant a variation to the terms of the marketing authorisation for the veterinary medicinal product Circovac. The Marketing Authorisation Holder for this veterinary medicinal product is Merial S.A.S.
The change agreed by the CVMP concerns use of the vaccine in a new target category of animals: piglets.
Detailed conditions for the use of this product will be described in the updated Summary of Product Characteristics (SPC) which will be published in the revised European Public Assessment Report (EPAR) and will be available in all official European Union languages after the variation/extension to the marketing authorisation has been granted by the European Commission”.